Related Experiment Videos
[Beta thalassemia major in Argentina]
Feliu Aurora Torres1, Mariana Bonduel, Gabriela Sciuccati
1Servicio de Hematología-Oncología, Hospital de Pediatría Prof. Dr. Juan P. Garrahan, Combate de los Pozos 1881, 1245 Buenos Aires, Argentina. afeliutorres@yahoo.com
Medicina
|June 1, 2002
Summary
Beta thalassemia major treatment is challenging, particularly for Italian immigrant families in Argentina. Economic constraints significantly impact patient outcomes and care accessibility.
Area of Science:
- Hematology
- Genetics
- Pediatrics
Context:
- Beta thalassemia major is a severe inherited blood disorder.
- This study analyzed patients at Hospital Juan P. Garrahan from 1987-2000.
- The population comprised 45 patients, predominantly of Italian immigrant descent.
Purpose:
- To characterize the patient population with beta thalassemia major.
- To evaluate treatment outcomes and identify associated complications.
- To understand the genetic defects prevalent in this cohort.
Summary:
- Common beta globin gene defects included C-39 (30.7%) and IVS-I nt 110 (20%).
- Growth assessments revealed short stature in 5 boys, and endocrine issues like delayed puberty (35.7%) and GH/IGF-I axis abnormalities (12.5%) were noted.
- Allogeneic stem cell transplantation was performed in 7 patients; 3 patients died from cardiac failure, CNS bleeding, or sepsis. Forty-two patients remain alive.
Impact:
- Highlights the complex management of beta thalassemia major.
- Underscores the significant impact of socioeconomic factors on treatment efficacy and patient prognosis.
- Provides insights into the genetic landscape and clinical manifestations in a specific Argentinian cohort.